Day 1
Tuesday, April 26, 2022
11:30-11:55 AM
Registration and box lunch -- Great Room Foyer
11:55-12:00pm
Welcome/Opening- Great Room
David Cassak, Editor-in-Chief, MedTech Strategist
Stephen Levin, Editor-in-Chief, Market Pathways
12:00-12:45pm
Venture Panel: The View from Europe
Arthur Franken, General Partner, Gilde Healthcare Partners
Caroline Gaynor, Principal, Lightstone Ventures
Helen McBreen, Partner, Atlantic Bridge
Antoine Papiernik, Chairman & Managing Partner, Sofinnova Partners
Alexander Schmitz, Partner, Endeavour Vision
David Cassak, Editor-in-Chief, MedTech Strategist
12:45-1:15pm
Keynote Session – Exit? We Don’t Need No Stinking Exit!
Chris Cleary, Senior Vice President of Corporate Development, Medtronic
1:20-1:25pm
Moderator - Medmarc
1:25-1:35pm
1:35-1:45pm
1:45-1:55pm
1:55-2:05pm
2:05-2:15pm
2:15-2:25pm
2:25-2:35pm
2:35-3:10pm
Ireland for Innovative Medical Technologies
Alan Hobbs, Manager High Potential Start Ups, Enterprise Ireland
Finbar Dolan, CEO, Versono Medical Ltd.
Suzanne Moloney, CEO, Hidramed Solutions Ltd.
Judi O’Malley, CEO, Spiorad Medical Ltd.
David van Zuydam, CEO, Head Diagnostics Ltd.
3:10-3:30pm
Networking Break - Great Room Foyer
3:30-3:35pm
Moderator – Addleshaw Goddard (formerly Eugene F. Collins)
3:35-4:15pm
Building Your People Organisation from Early-Stage to Commercialisation
Olivier Delporte, CEO, Miracor Medical
Olivier Litzka, Partner, Andera Partners
Ross O’Neill, Founder & CEO, Neuromod Devices
Karl Schweitzer, Founder & CEO, Transform Medical
Agata Lindenthal, Senior Consultant), HTI Healthcare and Technology International (moderator)
4:20-4:25pm
Moderator - Greenlight Guru
4:25-4:35pm
4:35-4:45pm
4:45-4:55pm
4:55-5:05pm
5:05-5:15pm
5:15-5:25pm
5:25-5:35pm
5:35-6:35pm
MedTech Innovator-Dublin
Host: Paul Grand, Founder & CEO, MedTech Innovator
Judges:
Jake Goble, Innovation Leader, WL Gore
Jinny Lee, SVP, Exploration, Strategy and Marketing, Edwards Lifesciences
Bruce Rosengard, Vice President for Medical Devices, Johnson & Johnson External Innovation
6:35-7:45pm
Networking Reception
Day 2
Wednesday, April 27, 2022
8:00-8:30am
Registration & Welcome Coffee -- Great Room Foyer
8:30-8:35am
Moderator - Minnetronix Medical
8:35-8:45am
8:45-8:55am
8:55-9:05am
9:05-9:15am
9:15-9:25am
9:25-10:05am
Keynote: Medtech 2022……where do we go after the pandemic?
Chris Cleary, Senior Vice President of Corporate Development, Medtronic
Anne Portwich, Partner, EQT Life Sciences
John Babitt, Partner, EY (moderator)
10:05-10:35am
MedTech by the Numbers
Barbara Castellano, Partner, Panakes Partners
Frederik Groenewegen, General Partner, 415 Capital
Ruben Osnabrugge, Investment Manager, EQT Life Sciences
Aneta Sottil, Director, Andera Partner
Jennifer McMahon, Partner, Seroba Life Sciences (moderator)
10:35-10:55am
Networking Break -- Great Room Foyer
10:55-11:25am
Fireside Chat
Todd Brinton, Chief Scientific Officer & Corporate Vice President, Edwards Lifesciences
David Cassak, Editor-in-Chief, MedTech Strategist
11:30am-12:00pm
The New Post Pandemic Supply Chain Issues for Medtech
Colin Doolin, Associate Partner, Global Trade, EY
Gary Curran, Senior Manager, EY
12:00-12:30pm
Venture Panel: The View from the US
Tak Cheung, Partner, NEA
James Eadie, Partner, Sante Ventures
Hanson Gifford, III, Partner, Lightstone Ventures
Megan MacDonagh, Senior Associate, SV Health Investors
David Cassak, Editor-in-Chief, MedTech Strategist
12:30-1:00pm
Commercialization and the Regulatory Path
Lucy O’Keeffe, CEO, CroiValve
Isabella Schmitt, Director of Regulatory Affairs, Proxima Clinical Research
Susan Trent, CEO, Atlantic Therapeutics
John Olden, Partner, Addleshaw Goddard (Moderator)
1:00-2:15pm
Lunch (Saddle Room) Lobby Level
2:15-2:45pm
Regulatory Changes in China: New Opportunities or Same Old Risks?
Jose Calle Gordo, Operating Partner, Valiance/Former CEO, Biosensors
Eliane Schutte, CEO, Xeltis
Ari Silverman, Partner, Mavie Technologies
Stephen Levin, Editor-in-Chief, Market Pathways (moderator)
2:50-2:55pm
Moderator - TTP
2:55-3:05pm
3:05-3:15pm
3:15-3:25pm
3:25-3:35pm
3:35-3:45pm
3:45-4:05pm
Networking Break -- Great Room Foyer
4:05-4:35pm
MDR is Here: Now What Does It Mean?
Serge Bernasconi, CEO, MedTech Europe
Gloria Crispino, CEO, StasticaMedica
Jeff Jump, CEO, Medalliance
Marc-Pierre Möll, CEO, BVMed
Stephen Levin, Editor-in-Chief, Market Pathways (moderator)
4:35-4:40pm
Moderator - EIT Health
4:40-5:10pm
VC Panel: New Models in Company Creation and Funding
Mudit Jain, Founding General Partner, Treo Ventures, CEO and co-founder of NuXcel
Howard Levin, CEO, Deerfield Catalyst
Andy McGibbon, Managing Partner, Sonder Capital
David Cassak, Editor-in-Chief, MedTech Strategist (moderator)
5:10-5:20pm
Integrated Translational Research: Advanced preclinical methods support product differentiation
Peter Markham, President & CEO, CBSET
5:20-5:30pm
5:30-5:40pm
5:40-5:50pm
5:50-6:00pm
6:00-7:30pm
Reception
Day 3
Thursday, April 28, 2022
8:00-8:30am
Registration & Welcome Coffee -- Great Room Foyer
8:20-9:00am
Tracking the Changing Reimbursement Landscape
Josh Makower, Professor of Medicine & Bioengineering, Stanford Biodesign
Harry Rowland, CEO, Endotronix
Dan Rose, CEO, LimFlow
Stephen Levin, Editor-in-Chief, Market Pathways (moderator)
9:00-9:05am
Moderator - NAMSA
9:05-9:15am
9:15-9:25am
Vectorious Medical Technologies
9:25-9:35am
9:35-9:45am
9:45-9:55am
9:55-10:05am
10:10-10:40am
Accelerating Medtech Innovation In The Current Global Reality
Jake Goble, Innovation Leader, WL Gore
Jinny Lee, SVP, Exploration, Strategy and Marketing, Edwards Lifesciences
Jennifer Nagy, General Manager, Ethicon GB
Eric Schantz, Vice President, Corporate Development, Medtronic
Lisa Carmel, Executive Vice President, Strategic Partnerships, Veranex (Moderator)
10:45-11:15am
Investor Views on Opportunities in Digital and HealthTech
Janke Dittmer, Partner, Gilde Healthcare Partners
Dennis McWilliams, Partner, Sante Ventures
Thom Rasche, Managing Partner, Earlybird Venture Capital
Josep Sanfeliu, Managing Partner, Asabys Partners
David Cassak, Editor-in-Chief, MedTech Strategist (moderator)
11:15-11:45am
Fireside Chat
Bruce Rosengard, Vice President for Medical Devices, Johnson & Johnson External Innovation
David Cassak, Editor-in-Chief, MedTech Strategist
11:45-12:05pm
Networking Break & Working Box Lunch -- Great Room Foyer
12:05-12:10pm
Veranex
12:10-12:20pm
12:20-12:30pm
12:30-12:40pm
12:40-12:50pm
12:50-12:55pm
Moderator - EY
12:55-1:05pm
1:05-1:15pm
1:15-1:25pm
New View Surgical
1:30pm-2:00pm
The Medtech Landscape Is Changing Rapidly. Can Corporate M&A Keep Up?
Christopher Eso, Vice President, Business Development & Strategy, CardioVascular Portfolio & SH&A, Medtronic
Susan Morano, Vice President Business Development and Strategic Operations, Johnson & Johnson
Rupert Winckler, Head of Business Development, EMEA, Olympus
David Cassak, Editor-in-Chief, MedTech Strategist (moderator)
2:00pm-2:30pm
Device IPOs’ Outlook: Sustainable or Just a Fling?
Mark Secrest, Managing Director, Healthcare Investment Banking, BTIG
Stephen Levin, Editor-in-Chief, Market Pathways
2:30pm
Event concludes